Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, the Mounjaro needle causes little more than a brief, mild sting — many describe it as barely noticeable. The KwikPen uses a very fine, short needle, and the injection itself takes only a second or two. That said, a small number of people do experience more than a sting, and there are straightforward reasons why, and straightforward fixes. Mounjaro (tirzepatide) is a prescription-only medicine for weight management, so a prescriber will always be involved before you start; they can run through injection technique with you before your first dose.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks: "I've read that injections hurt, should I be worried?" The short answer is that the pen is engineered to be as gentle as possible. The needle is ultrafine and short, comparable to the needles used in insulin pens that people self-inject with daily. Most people report a brief, mild sensation at most.
What causes more noticeable discomfort tends to be technique rather than the needle itself. Injecting into the same spot repeatedly, tensing the muscle, or rushing the injection all amplify the sensation. Skin that is particularly thin or sensitive (the inner thigh, for example) can feel sharper than the outer abdomen. Body composition plays a role too: less subcutaneous fat means less cushion between the needle and muscle.
It is also worth knowing that some people feel more at first doses and less as they settle into their weekly routine. The anticipation of an injection often registers as more unpleasant than the act itself, and that tends to even out with practice. If you find the technique genuinely difficult, our Mounjaro injection guide covers the full process step by step.
Yes, meaningfully. The three licensed injection sites (abdomen, outer thigh and upper arm) each have different amounts of subcutaneous tissue, and that changes the experience. The outer abdomen (at least a few centimetres from the navel) is usually the most comfortable starting point for people new to self-injection. The outer thigh works well too. The upper arm is fine but trickier to reach without help.
Rotating between sites every week is not optional extra advice. Injecting repeatedly into exactly the same patch of skin causes localised soreness, small lumps of hardened tissue called lipohypertrophy, and can even change how the medicine is absorbed. The reasons a Mounjaro injection site stays sore are almost always related to this, inject somewhere new each time and most site-specific soreness resolves.
Pinching the skin gently before inserting the needle, then releasing and pressing slowly on the injector button, gives the medicine time to disperse rather than pooling. Cleaning the area first with an alcohol swab and letting it dry fully before you inject also reduces the sharp sting some people notice.
This is the single most practical tip for anyone who finds the injection stings: do not inject straight from the fridge. Mounjaro is stored refrigerated at 2–8°C, and a cold solution injected into skin genuinely hurts more, the nerve endings in the skin are more reactive to cold liquid. Taking the pen out 20 to 30 minutes before your scheduled injection time, leaving it on the counter, is usually enough to take the edge off.
Do not warm the pen artificially with hot water, a microwave or direct heat, this can degrade the medicine. And never freeze it. For the full guidance on storing your pen, including the limited room-temperature window permitted by the manufacturer, the NHS tirzepatide page sets out the key points clearly, and the Patient Information Leaflet included in the box is the definitive reference for your specific pen.
If you want to read more about the pen itself (how it is loaded, how the mechanism works and how to change the needle correctly) the Mounjaro pen and needle detail page has that in full.
Mild tenderness at the injection site for a day or two is normal and listed in the medicine's side-effect profile. Redness, minor bruising and faint itching are also recognised and typically minor. These settle on their own.
Contact your prescriber if you notice: a raised, firm lump at a site that is not fading after a week; spreading redness, warmth or swelling that looks like an infection; intense pain rather than mild soreness; or any sign of an allergic reaction such as a rash, itching or swelling away from the injection site. The broader guide on Mounjaro injection discomfort lists these red flags in detail. You can also report any suspected side effect directly to the MHRA via the Yellow Card scheme, that reporting helps regulators track patterns across the population.
Tirzepatide is a prescription-only medicine, which means a clinician reviews your case before and during treatment. If injection discomfort is putting you off taking your dose, that is exactly the kind of thing to raise with your prescriber, adjusting technique, site or timing often resolves it without any change to the dose itself. If you are weighing up options and want to understand the injection versus a daily tablet, this comparison of tirzepatide delivery formats may help you think it through before your consultation.
When you are ready to talk to a clinician, starting a free consultation puts your question in front of a GPhC-registered Independent Prescriber the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.